Octagon Capital Advisors
$1.1B 13F equity value
33 Holdings
Latest filing 2026-06-30
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 1,841,667 | $180M | 16.5% |
| DFTX | DEFINIUM THERAPEUTICS INC | 2,950,000 | $139M | 12.7% |
| ABVX | ABIVAX SA | 993,000 | $132M | 12.1% |
| COGT | COGENT BIOSCIENCES INC | 2,350,000 | $91M | 8.3% |
| ALMS | ALUMIS INC | 2,830,700 | $80M | 7.3% |
| AVBP | ARRIVENT BIOPHARMA INC | 1,971,054 | $68M | 6.3% |
| TSHA | TAYSHA GENE THERAPIES INC | 9,693,244 | $66M | 6.1% |
| BIOA | BIOAGE LABS INC | 1,748,000 | $43M | 3.9% |
| MIRM | MIRUM PHARMACEUTICALS INC | 338,900 | $40M | 3.6% |
| KYMR | KYMERA THERAPEUTICS INC | 310,000 | $36M | 3.3% |
Track Octagon Capital Advisors's 13F portfolio: $1.1B in reported holdings, 33 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}